Physician profile
Jonathan Dickens
NPI 1578769022
$12,748.04
in general payments reported to CMS, 2019-2025
10 companies · $706 in 2025
The $706 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,306 · 2020: $1,711 · 2021: $3,713 · 2022: $2,535 · 2023: $397 · 2024: $1,380 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250 · Food and Beverage: $1,161 · Entertainment: $72.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
| Food and Beverage | $1,161.27 |
| Entertainment | $72.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $6,203.98 | 2019-2021 | |
| Arthrex, INC. | $2,868.44 | 2019-2024 | |
| Southtech Orthopedics | $2,400.00 | 2022 | |
| Tricoast Surgical Solutions LLC | $765.29 | 2022-2025 | |
| Stryker Corporation | $282.58 | 2021-2025 | Iconix, Hoffmann, Augment Injectable |
| Linvatec Corporation | $85.09 | 2022 | |
| Vericel Corporation | $72.37 | 2025 | Maci |
| Smith+Nephew, INC. | $43.09 | 2020 | |
| Restor3d, INC. | $27.20 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,527.21 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dickens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.